Stockholders’ Equity and Equity Incentive Plans (Tables)

9 Months Ended

Oct. 31, 2023

Stockholders' Equity Note [Abstract]

Schedule of Stock Option Activity Under Equity Incentive Plan

A summary of stock option activity under our equity incentive plan and related information is as follows:

	Stock Options
	Outstanding Stock Options	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value
	(in thousands, except share, life, and per share data)
Balance as of January 31, 2023	4,800,616	$	8.22	4.9	$	322,929
Exercised	(1,214,532)	$	6.86		$	75,266
Canceled/forfeited/expired	(22,230)	$	92.95
Outstanding and exercisable as of October 31, 2023	3,563,854	$	8.16	4.1	$	188,163

Schedule of Restricted Stock Units (RSUs) Activity Under Equity Incentive Plan

A summary of restricted stock unit (“RSU”) activity under our equity incentive plan and related information is as follows:

	RSUs
	RSUs	Weighted- Average Grant Date Fair Value Per Share
Unvested as of January 31, 2023	21,868,533	$	109.31
Granted	17,141,593	$	69.01
Vested	(8,747,679)	$	105.71
Canceled/forfeited	(3,772,653)	$	102.10
Unvested as of October 31, 2023	26,489,794	$	85.46

Schedule of Stock-based Compensation Expense by Line Item

The stock-based compensation expense by line item in the accompanying condensed consolidated statements of operations is summarized as follows:

	Three Months Ended October 31,				Nine Months Ended October 31,
	2023		2022		2023		2022
	(in thousands)
Cost of revenue	$	35,514	$	41,449	$	111,138	$	109,776
Research and development	86,662		83,202		250,165		208,654
Sales and marketing	86,593		125,144		293,104		329,100
General and administrative	50,165		53,020		148,381		120,163
Total stock-based compensation expense	$	258,934	$	302,815	$	802,788	$	767,693
Benefit from income taxes	(48,646)		(53,995)		(147,089)		(151,027)
Total stock-based compensation expense recorded to net income	$	210,288	$	248,820	$	655,699	$	616,666